Page last updated: 2024-08-24

pyrazolo(3,4-d)pyrimidine and HIV Infections

pyrazolo(3,4-d)pyrimidine has been researched along with HIV Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biava, M; Botta, M; Brullo, C; Carraro, F; Crespan, E; Esté, JA; Falchi, F; Kissova, M; La Rocca, F; Laurenzana, I; Maga, G; Ruiz, A; Schenone, S; Tintori, C1

Other Studies

1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and HIV Infections

ArticleYear
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.
    ChemMedChem, 2013, Volume: 8, Issue:8

    Topics: Anti-HIV Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Design; HIV Infections; HIV-1; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-hck; Pyrazoles; Pyrimidines; Virus Replication

2013